“ALPHA TRUST – ANDROMEDA Portfolio Investment Company S.A.” announces to the investing public that, by decision of the Company’s Board of Directors dated April 21,2026, the Company’s Board of Directors resolved to increase the share capital as part of the dividend reinvestment program from the distribution of profits for the fiscal year 2025 and prior fiscal years, following the granting of the relevant authorization by the Extraordinary General Meeting of Shareholders held on July 26,2023, in accordance with Article 24(1)(b) of Law 4548/2018, for the implementation of a five-year dividend reinvestment program (2023–2028) approved by the General Meeting.
Following the above, the Company’s Board of Directors, at its meeting on June 12, 2026, resolved to issue 20,368 new common, registered, voting shares with a par value of 3.44 euros each, resulting from the partial coverage of the share capital increase due to the reinvestment of the dividend.
The shares issued in accordance with the foregoing are allocated to eligible shareholders who declared their participation in the reinvestment of the aforementioned dividend, at an offering price equal to the volume-weighted average share price (VWAP) for the first five (5) trading days within the dividend reinvestment exercise period (i.e., from May 27, 2026, to June 3, 2026), reduced by 1% (discount rate). Based on the above, the offering price of the new shares was set at 8.35 euros.
It is noted that the beneficiaries of the aforementioned dividend are the Company’s shareholders who were registered in the Central Securities Depository (CSD) records as of May 26, 2026.
As part of the aforementioned reinvestment of the dividend from profits for the 2025 fiscal year and prior fiscal years—the distribution of which was decided pursuant to the resolution of the Company’s Annual General Meeting dated April 21, 2026— eligible shareholders were informed via relevant announcements on the stock exchange’s and the Company’s websites regarding their aforementioned right, as well as the timing, method, and procedure for exercising it.
This right was exercised by 11.40% of the total share capital, excluding treasury shares, resulting in a total of 20,368 new common, registered, voting shares.
As a result, the Company’s share capital increased by €70,065.92 and now amounts to €12,915.590.08, divided into 3,754,532 common registered shares with a par value of €3.44 each.
On June 15, 2026, the minutes of the Company’s Board of Directors meeting dated June 12, 2026, were filed with the General Commercial Registry (GEMI). the minutes of the Company’s Board of Directors dated June 12, 2026, by which a) it was confirmed that, in accordance with Article 20, paragraphs 4, 6, and 7, and Article 28 of Law 4548/2018, the certification of the payment of the amount of one hundred seventy thousand seventy-two euros and eighty cents (€170,072.80), through capitalization of a liability, and b) the amendment to Article 5 of the Company’s Articles of Association regarding share capital was approved, as described above.
On June 18, 2026, Euronext Athens approved the listing of the Company’s new shares for trading.
Consequently, trading on Euronext Athens of the 20,368 new common, registered, voting shares of the Company with a par value of €3.44 will commence on June 19, 2026.
As of the same date, these shares will be registered in the records of Euronext Securities Athens and in the securities accounts and holdings in the Central Securities Depository (CSD) declared by the aforementioned beneficiaries, as provided by law, and the price of the Company’s shares will be determined in accordance with the Euronext Athens Regulations and Decision No. 26 of the Stock Exchange’s Board of Directors, as amended and currently in force.